Article
BNT162b2-Elicited Neutralization of Delta Plus, Lambda, and Other Variants
2021-09-14
Abstract excerpt
BNT162b2-elicited human sera are known to neutralize the currently dominant Delta SARS-CoV-2 variant. Here, we report the ability of 20 human sera, drawn 2 or 4 weeks after two doses of BNT162b2, to neutralize USA-WA1/2020 SARS-CoV-2 bearing variant spikes from Delta plus (Delta-AY.1, Delta-AY.2), Delta-Δ144 (Delta with the Y144 deletion of the Alpha variant), Lambda, and B. 1.1.519 lineage viruses. Geometric mean...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a68de9d4-eebf-5b3b-abcb-3311bd4bc16a
- DOI
- 10.1101/2021.09.13.460163
